Concurrently, dysregulated biosynthesis of secondary bile acids, particularly deoxycholic acid, disrupts lipid homeostasis through Farnesoid X receptor (FXR)-mediated signaling cascades, ultimately contributing to hepatic insulin resistance and impaired glucose regulation (Sayin et al., 2013). The gene discussed is NR1H4; the disease is Insulin resistance.